Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease

Fig. 1

Overall mortality in the competing risk model (liver transplant as the competing risk) stratified by comorbidity burden using the Charlson Comorbidity Index (CCI) (excluding liver disease and liver cancer). The analysis was adjusted for age, gender, race, model for endstage liver disease with sodium modification, body mass index, liver disease etiology and presence of hepatocellular carcinoma. The sub-hazard ratio for each 1-point increment in CCI was 1.24 (95%confidence interval 1.1–1.4)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us